Home
About
Overview
Sharing Data
ORCID
Help
History (27)
Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping.
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study.
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?
Phenotypic Plasticity and Cancer: A System Biology Perspective.
See All 27 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phenotypic Plasticity and Cancer: A System Biology Perspective.
Phenotypic Plasticity and Cancer: A System Biology Perspective. J Clin Med. 2024 Jul 23; 13(15).
View in:
PubMed
authors with profiles
Ravi Salgia